Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in ichthyoses
NCT04549792Phase 1Completed
- Sponsor
- Northwestern University
- Start
- Apr 2021
- Primary completion
- Jan 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ustekinumab in ichthyosis, sponsored by Northwestern University. Primary endpoints: Reduction in Total Ichthyosis Severity Score at 7 months and Occurrence of Bacterial and Fungal Infections at 7 months. Started Apr 2021; status: completed.
02
Drugs
ustekinumab
03
Conditions
ichthyosis
Beyond the preview
Go deeper on NCT04549792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04549792.